Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 2, 2006, Pages 109-114

  Baboota, Sanjula ^a   Shakeel, F ^a   Kohli, K ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Antiinflammatory; Diclofenac diethylamine; Gels; Transdermal

Indexed keywords

CARBOPOL 940; DICLOFENAC DIETHYLAMINE; DIMETHYL SULFOXIDE; HYDROXYPROPYLMETHYLCELLULOSE; OIL; PENETRATION ENHANCING AGENT; PLASTICIZER; POLYMER; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; EDEMA; GEL; IN VITRO STUDY; NONHUMAN; PH; PHYSICAL CHEMISTRY; RAT; SKIN PERMEABILITY; STEADY STATE; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DRUG STABILITY; EDEMA; EXCIPIENTS; GELS; HYDROGEN-ION CONCENTRATION; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLUBILITY; TEMPERATURE; VISCOSITY;

EID: 33646243207     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.2.977842     Document Type: Article

References (12)

1. John, V.A. The pharmacokinetics and metabolism of diclofenac sodium in animals and man. Rheumatol Rehab, 1979, 2 (Suppl): 22-37.
2. Kriwet, K., Muller, G. Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int J Pharm 1995, 125: 231-42.
3. Chien, Y.W. Transdermal Controlled Systemic Medication. Marcel Dekker: New York 1987, 159-76.
4. Knutson, K., Krill, S.L., Lambert, W.J., Higuchi, W.I. Physicochemical aspects of transdermal permeaion. J Control Release 1987, 6: 59-74.
5. Keith, A.D. Polymer matrix consideration for transdermal devices. Drug Dev Ind Pharm 1983, 9: 605-21.
6. Alvarez-Figueroa, M.S., Blasnco-Mendez, J. Transdermal delivery of methotrexate: Iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001, 215: 57-65.
7. Beetge, E., Plessis, J.D., Muller, D.G., Goosen, C., Renburg, F.J.V. The influence of the physicochemical characteristics and pharmacokinetics properties of selected NSAIDs on their transdermal absorption. Int J Pharm 2000, 193: 261-4.
8. Kikwai, L., Kanikkannan, N., Babu, R.J., Singh, M. Effects of vehicles on transdermal delivery of melatonin across porcine skin in-vitro. J Control Release 2002, 83: 307-11.
9. Jia-You, E., Tsonglong, H., Yannlii, L. Effects of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int J Pharm 2003, 250: 313-25.
10. Gobiga, H., Cal, K., Janicki, S. Effects of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Indian J Pharm Sci 2000, 199: 1-6.
11. Arora, A., Mukherjee, B. Design, development, physicochemical and in-vitro and in-vivo evaluation of transdermal patches containing diclofenac diehylammonium salt. J Pharm Sci 2002, 91: 2076-89.
12. Fites, A.L., Banker, G.S., Smolen, V.F. Controlled drug release through polymeric films. J Pharm Sci 1970, 59: 610-13.